Repository logo
Log In
Log in as University member:
Log in as external user:
Have you forgotten your password?

Please contact the hohPublica team if you do not have a valid Hohenheim user account (hohPublica@uni-hohenheim.de)
Hilfe
  • English
  • Deutsch
    Communities & Collections
    All of hohPublica
Log In
Log in as University member:
Log in as external user:
Have you forgotten your password?

Please contact the hohPublica team if you do not have a valid Hohenheim user account (hohPublica@uni-hohenheim.de)
Hilfe
  • English
  • Deutsch
  1. Home
  2. Person

Browsing by Person "Renner, Olga"

Type the first few letters and click on the Browse button
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Publication
    The therapeutic potential of vitamins A, C, and D in pancreatic cancer
    (2025) Piotrowsky, Alban; Burkard, Markus; Schmieder, Hendrik; Venturelli, Sascha; Renner, Olga; Marongiu, Luigi
    The pancreatic ductal adenocarcinoma (PDAC) is among the deadliest tumor diseases worldwide. While treatment options have generally become more diverse, little progress has been made in the treatment of PDAC and the median survival time for patients with locally advanced PDAC is between 8.7 and 13.7 months despite treatment. The aim of this review was to explore the therapeutic potential of complementing standard therapy with natural or synthetic forms of vitamins A, C, and D. The therapeutic use of vitamins A, C, and D could be a promising addition to the treatment of PDAC. For all three vitamins and their derivatives, tumor cell-specific cytotoxicity and growth inhibition against PDAC cells has been demonstrated in vitro and in preclinical animal models. While the antitumor effect of vitamin C is probably mainly due to its pro-oxidative effect in supraphysiological concentrations, vitamin A and vitamin D exert their effect by activating nuclear receptors and influencing gene transcription. In addition, there is increasing evidence that vitamin A and vitamin D influence the tumor stroma, making the tumor tissue more accessible to other therapeutic agents. Based on these promising findings, there is a high urgency to investigate vitamins A, C, and D in a clinical context as a supplement to standard therapy in PDAC. Further studies are needed to better understand the exact mechanism of action of the individual compounds and to develop the best possible treatment regimen. This could contribute to the long-awaited progress in the treatment of this highly lethal tumor entity.

  • Contact
  • FAQ
  • Cookie settings
  • Imprint/Privacy policy